Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs

JM Harouse, A Gettie, RCH Tan, J Blanchard… - Science, 1999 - science.org
JM Harouse, A Gettie, RCH Tan, J Blanchard, C Cheng-Mayer
Science, 1999science.org
Infection of macaques with chimeric simian–human immunodeficiency virus (SHIV) provides
an excellent in vivo model for examining the influence of envelope on HIV-1 pathogenesis.
Infection with a pathogenic CCR5 (R5)–specific enveloped virus, SHIVSF162P, was
compared with infection with the CXCR4 (X4)–specific SHIVSF33A. 2. Despite comparable
levels of viral replication, animals infected with the R5 and X4 SHIV had distinct pathogenic
outcomes. SHIVSF162P caused a dramatic loss of CD4+ intestinal T cells followed by a …
Infection of macaques with chimeric simian–human immunodeficiency virus (SHIV) provides an excellent in vivo model for examining the influence of envelope on HIV-1 pathogenesis. Infection with a pathogenic CCR5 (R5)–specific enveloped virus, SHIVSF162P, was compared with infection with the CXCR4 (X4)–specific SHIVSF33A.2. Despite comparable levels of viral replication, animals infected with the R5 and X4 SHIV had distinct pathogenic outcomes. SHIVSF162P caused a dramatic loss of CD4+ intestinal T cells followed by a gradual depletion in peripheral CD4+ T cells, whereas infection with SHIVSF33A.2 caused a profound loss in peripheral T cells that was not paralleled in the intestine. These results suggest a critical role of co-receptor utilization in viral pathogenesis and provide a reliable in vivo model for preclinical examination of HIV-1 vaccines and therapeutic agents in the context of the HIV-1 envelope protein.
AAAS